Stemsation International Inc
Stemsation International, Inc. researches, develops, manufactures, and sells canned and flavored oxygen products in the United States. The company sells its products through business to business and direct to consumers channels. Stemsation International, Inc. was incorporated in 2006 and is headquartered in Plantation, Florida.
Stemsation International Inc (STSN) - Net Assets
Latest net assets as of March 2025: $11.38 Million USD
Based on the latest financial reports, Stemsation International Inc (STSN) has net assets worth $11.38 Million USD as of March 2025.
Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets ($12.99 Million) and total liabilities ($1.60 Million). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | $11.38 Million |
| % of Total Assets | 87.64% |
| Annual Growth Rate | 38.11% |
| 5-Year Change | N/A |
| 10-Year Change | N/A |
| Growth Volatility | 1567.45 |
Stemsation International Inc - Net Assets Trend (2006–2024)
This chart illustrates how Stemsation International Inc's net assets have evolved over time, based on quarterly financial data. Explore and compare other companies by net assets.
Annual Net Assets for Stemsation International Inc (2006–2024)
The table below shows the annual net assets of Stemsation International Inc from 2006 to 2024.
| Year | Net Assets | Change |
|---|---|---|
| 2024-12-31 | $11.46 Million | +1779.41% |
| 2023-12-31 | $-682.23K | +20.02% |
| 2022-12-31 | $-852.95K | +5.02% |
| 2021-12-31 | $-898.07K | -290.21% |
| 2020-12-31 | $-230.15K | -416.84% |
| 2019-12-31 | $-44.53K | -6109.21% |
| 2018-12-31 | $-717.16 | +99.90% |
| 2017-12-31 | $-687.58K | -3691.97% |
| 2010-12-31 | $19.14K | +112.23% |
| 2007-12-31 | $-156.55K | -557.08% |
| 2006-12-31 | $34.25K | -- |
Equity Component Analysis
This analysis shows how different components contribute to Stemsation International Inc's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have decreased by 610865300.0% over the analyzed period, potentially due to dividend distributions or operating losses.
Current Equity Component Breakdown (December 2024)
| Component | Amount | Percentage |
|---|---|---|
| Common Stock | $62.05K | 0.54% |
| Other Comprehensive Income | $9.18K | 0.08% |
| Other Components | $17.52 Million | 152.93% |
| Total Equity | $11.46 Million | 100.00% |
Stemsation International Inc Competitors by Market Cap
The table below lists competitors of Stemsation International Inc ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
Kasten Inc
PINK:KAST
|
$62.24 |
|
World Oil Group
PINK:MONI
|
$62.25 |
|
NFT Technologies Inc
PINK:NFTFF
|
$62.57 |
|
MERIDIAN-MARSHALLS HOLDING COMPANY LIMITED
GSE:MMH
|
$62.63 |
|
Bit Brother Limited
PINK:BETSF
|
$62.00 |
|
Enteq Upstream
LSE:NTQ
|
$61.89 |
|
ABBEY MORTGAGE BANK PLC
XNSA:ABBEYBDS
|
$61.62 |
|
Tess Agro PLC
CM:TESSN0000
|
$61.59 |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Stemsation International Inc's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2023 to 2024, total equity changed from -682,227 to 11,457,377, a change of 12,139,604.
- Net loss of 896,647 reduced equity.
- Other factors increased equity by 13,036,251.
Equity Change Factors (2023 to 2024)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | $-896.65K | -7.83% |
| Other Changes | $13.04 Million | +113.78% |
| Total Change | $- | % |
Book Value vs Market Value Analysis
This analysis compares Stemsation International Inc's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 0.16x
- The company is trading below its book value, potentially indicating the market believes the assets are overvalued on the balance sheet or anticipates future losses.
- The price-to-book ratio has decreased from 1.13x to 0.16x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | $0.01 | $0.01 | x |
| 2007-12-31 | $-0.02 | $0.01 | x |
| 2008-12-31 | $0.00 | $0.01 | x |
| 2009-12-31 | $0.00 | $0.01 | x |
| 2010-12-31 | $0.00 | $0.01 | x |
| 2017-12-31 | $-0.03 | $0.01 | x |
| 2018-12-31 | $0.00 | $0.01 | x |
| 2019-12-31 | $0.00 | $0.01 | x |
| 2020-12-31 | $0.00 | $0.01 | x |
| 2021-12-31 | $0.00 | $0.01 | x |
| 2022-12-31 | $0.00 | $0.01 | x |
| 2023-12-31 | $0.00 | $0.01 | x |
| 2024-12-31 | $0.04 | $0.01 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Stemsation International Inc utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): -7.83%
- The company may be facing challenges in efficiently utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 0.00%
- • Asset Turnover: 0.00x
- • Equity Multiplier: 1.13x
- Recent ROE (-7.83%) is above the historical average (-60.34%), indicating improving capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | -77.78% | 0.00% | 0.00x | 4.21x | $-30.06K |
| 2007 | 0.00% | 0.00% | 0.00x | 0.00x | $-431.70K |
| 2008 | 0.00% | 0.00% | 0.00x | 0.00x | $-266.55K |
| 2009 | 0.00% | 0.00% | 0.00x | 0.00x | $-58.50K |
| 2010 | -698.79% | -3963.32% | 0.01x | 17.04x | $-135.68K |
| 2017 | 0.00% | 0.00% | 0.00x | 0.00x | $38.72K |
| 2018 | 0.00% | 0.00% | 0.00x | 0.00x | $-29.51K |
| 2019 | 0.00% | -25843.45% | 0.02x | 0.00x | $-831.84K |
| 2020 | 0.00% | -481.77% | 2.70x | 0.00x | $-1.02 Million |
| 2021 | 0.00% | 0.00% | 0.00x | 0.00x | $-1.06 Million |
| 2022 | 0.00% | 0.00% | 0.00x | 0.00x | $-353.18K |
| 2023 | 0.00% | 0.00% | 0.00x | 0.00x | $-19.05K |
| 2024 | -7.83% | 0.00% | 0.00x | 1.13x | $-2.04 Million |
Industry Comparison
This section compares Stemsation International Inc's net assets metrics with peer companies in the Drug Manufacturers - Specialty & Generic industry.
Industry Context
- Industry: Drug Manufacturers - Specialty & Generic
- Average net assets among peers: $548,450,613
- Average return on equity (ROE) among peers: -450.37%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Stemsation International Inc (STSN) | $11.38 Million | -77.78% | 0.14x | $62.07 |
| Ascend Wellness Holdings Inc (AAWH) | $142.87 Million | -33.75% | 5.44x | $48.90 Million |
| AB Science S.A (ABSCF) | $10.73 Million | -252.65% | 3.71x | $39.89 Million |
| Alterola Biotech Inc (ABTI) | $4.85K | -2005.32% | 0.49x | $603.58K |
| Aurora Cannabis Inc (ACB) | $2.04 Billion | -34.08% | 0.34x | $199.15 Million |
| Acreage Holdings Inc (ACRDF) | $204.27 Million | -30.85% | 1.41x | $13.48K |
| Acura Pharmaceuticals Inc (ACUR) | $7.90 Million | -63.15% | 1.15x | $13.20K |
| Agra Ventures Ltd. (AGFAF) | $1.51 Million | -44.22% | 0.06x | $298.23K |
| Allergy Therapeutics plc (AGYTF) | $2.07 Million | -2084.75% | 31.32x | $25.30 Million |
| Aida Pharmaceuticals Inc (AIDA) | $6.67 Million | 24.51% | 2.78x | $1.80 |
| Adcock Ingram Holdings Limited (AIHLF) | $3.07 Billion | 20.55% | 0.55x | $85.61 Million |